The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Unicorn Fund
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unicorn Fund, a non-promoter entity, has disclosed acquisition of 4,77,000 equity shares in Accretion Nutraveda Ltd, representing 6.5583% of the company's total share capital. The bulk of the acquisition (4,71,000 shares) came through the company's IPO as an Anchor Investor, with an additional 6,000 shares purchased on the secondary market in early February 2026. Prior to this acquisition, Unicorn Fund held NIL shares, meaning this is a fresh entry that crossed the 5% SEBI disclosure threshold. The holding is now reported as 6.5583% of both total and diluted share capital.
This is a mandatory regulatory disclosure triggered by Unicorn Fund crossing the 5% substantial acquisition threshold. Since the bulk of the shares came via the IPO anchor book, it signals institutional confidence in the offering. Investors should note that a 6.56% non-promoter holding increases public float awareness and may influence post-listing trading dynamics.